EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
03 2021
Historique:
received: 09 09 2020
revised: 05 11 2020
accepted: 22 11 2020
pubmed: 26 11 2020
medline: 2 4 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

The study was undertaken to identify a monogenic cause of early onset, generalized dystonia. Methods consisted of genome-wide linkage analysis, exome and Sanger sequencing, clinical neurological examination, brain magnetic resonance imaging, and protein expression studies in skin fibroblasts from patients. We identified a heterozygous variant, c.388G>A, p.Gly130Arg, in the eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2) gene, segregating with early onset isolated generalized dystonia in 5 patients of a Taiwanese family. EIF2AK2 sequencing in 191 unrelated patients with unexplained dystonia yielded 2 unrelated Caucasian patients with an identical heterozygous c.388G>A, p.Gly130Arg variant, occurring de novo in one case, another patient carrying a different heterozygous variant, c.413G>C, p.Gly138Ala, and one last patient, born from consanguineous parents, carrying a third, homozygous variant c.95A>C, p.Asn32Thr. These 3 missense variants are absent from gnomAD, and are located in functional domains of the encoded protein. In 3 patients, additional neurological manifestations were present, including intellectual disability and spasticity. EIF2AK2 encodes a kinase (protein kinase R [PKR]) that phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2α), which orchestrates the cellular stress response. Our expression studies showed abnormally enhanced activation of the cellular stress response, monitored by PKR-mediated phosphorylation of eIF2α, in fibroblasts from patients with EIF2AK2 variants. Intriguingly, PKR can also be regulated by PRKRA (protein interferon-inducible double-stranded RNA-dependent protein kinase activator A), the product of another gene causing monogenic dystonia. We identified EIF2AK2 variants implicated in early onset generalized dystonia, which can be dominantly or recessively inherited, or occur de novo. Our findings provide direct evidence for a key role of a dysfunctional eIF2α pathway in the pathogenesis of dystonia. ANN NEUROL 2021;89:485-497.

Identifiants

pubmed: 33236446
doi: 10.1002/ana.25973
pmc: PMC7986743
doi:

Substances chimiques

EIF2AK2 protein, human EC 2.7.11.1
eIF-2 Kinase EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-497

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Lancet Neurol. 2018 Jul;17(7):597-608
pubmed: 29887161
Eur J Hum Genet. 2017 Feb;25(2):176-182
pubmed: 27848944
Cell Mol Life Sci. 2013 Oct;70(19):3493-511
pubmed: 23354059
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Neurobiol Dis. 2017 Feb;98:52-65
pubmed: 27890709
Mov Disord. 2013 Sep;28(10):1325-9
pubmed: 23736975
Lancet Neurol. 2008 Mar;7(3):207-15
pubmed: 18243799
Viruses. 2012 Oct 29;4(11):2598-635
pubmed: 23202496
Nat Rev Dis Primers. 2018 Sep 20;4(1):25
pubmed: 30237473
EMBO J. 1998 Aug 3;17(15):4379-90
pubmed: 9687506
Neuroscience. 2018 Feb 10;371:455-468
pubmed: 29289717
FEBS J. 2015 Dec;282(24):4766-81
pubmed: 26414443
Mol Cell. 2018 Feb 15;69(4):622-635.e6
pubmed: 29429924
Neurobiol Dis. 2020 Dec;146:105135
pubmed: 33049316
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
J Cell Biochem. 2019 Nov;120(11):19004-19018
pubmed: 31246344
Expert Rev Mol Med. 2017 Jul 20;19:e9
pubmed: 28724458
Ann Neurol. 2016 Feb;79(2):244-56
pubmed: 26528954
Mov Disord. 2016 May;31(5):765-7
pubmed: 26990861
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Struct Mol Biol. 2009 Jan;16(1):63-70
pubmed: 19043413
Neurobiol Learn Mem. 2013 Oct;105:93-9
pubmed: 23707798
FEBS J. 2019 Jan;286(2):342-355
pubmed: 29476642
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
Neuron. 2016 Dec 21;92(6):1238-1251
pubmed: 27939583
J Biol Chem. 2015 Sep 11;290(37):22543-57
pubmed: 26231208
Am J Hum Genet. 2020 Apr 2;106(4):570-583
pubmed: 32197074
Curr Neurol Neurosci Rep. 2017 Oct 30;17(12):97
pubmed: 29086067
J Inherit Metab Dis. 2018 Nov;41(6):1077-1091
pubmed: 29948482
PLoS Genet. 2018 Jan 24;14(1):e1007169
pubmed: 29364887
Biochem J. 2002 Aug 15;366(Pt 1):175-86
pubmed: 11985496
Sci Rep. 2016 Sep 16;6:32886
pubmed: 27633668
Nat Genet. 2002 Jan;30(1):97-101
pubmed: 11731797
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Brain Res. 2019 Mar 1;1706:24-31
pubmed: 30366018
Mov Disord. 2019 Oct;34(10):1516-1527
pubmed: 31216378

Auteurs

Demy J S Kuipers (DJS)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Wim Mandemakers (W)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Chin-Song Lu (CS)

Professor Lu Neurological Clinic, Taoyuan, Taiwan.
Section of Movement Disorders, Department of Neurology and Neuroscience Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Simone Olgiati (S)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Guido J Breedveld (GJ)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Christina Fevga (C)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Vera Tadic (V)

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Miryam Carecchio (M)

Medical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.
Department of Neuroscience, University of Padua, Padua, Italy.

Bradley Osterman (B)

Division of Child Neurology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

Lena Sagi-Dain (L)

Genetics Institute, Carmel Medical Center, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Yah-Huei Wu-Chou (YH)

Department of Medical Research, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Chiung C Chen (CC)

Section of Movement Disorders, Department of Neurology and Neuroscience Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Department of Medicine, Chang Gung University, Taoyuan, Taiwan.

Hsiu-Chen Chang (HC)

Professor Lu Neurological Clinic, Taoyuan, Taiwan.
Section of Movement Disorders, Department of Neurology and Neuroscience Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Shey-Lin Wu (SL)

Department Neurology, Changhua Christian Hospital, Chunghua, Taiwan.

Tu-Hsueh Yeh (TH)

Department of Neurology, Taipei Medical University Hospital, Taipei, Taiwan.
School of Medicine, Taipei Medical University, Taipei, Taiwan.

Yi-Hsin Weng (YH)

Section of Movement Disorders, Department of Neurology and Neuroscience Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Department of Medicine, Chang Gung University, Taoyuan, Taiwan.

Antonio E Elia (AE)

Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Celeste Panteghini (C)

Medical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Nicolas Marotta (N)

Ken and Ruth Davee Department of Neurology and Simpson Querry Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Martje G Pauly (MG)

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Andrea A Kühn (AA)

Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität of Berlin and Humboldt, Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Jens Volkmann (J)

Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Baiba Lace (B)

Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada.

Inge A Meijer (IA)

Department of Neurosciences and Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.

Krishna Kandaswamy (K)

Centogene AG, Rostock, Germany.

Marialuisa Quadri (M)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Janssen Vaccines and Prevention, Leiden, the Netherlands.

Barbara Garavaglia (B)

Medical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Katja Lohmann (K)

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Peter Bauer (P)

Centogene AG, Rostock, Germany.

Niccolò E Mencacci (NE)

Ken and Ruth Davee Department of Neurology and Simpson Querry Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Steven J Lubbe (SJ)

Ken and Ruth Davee Department of Neurology and Simpson Querry Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Christine Klein (C)

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Aida M Bertoli-Avella (AM)

Centogene AG, Rostock, Germany.

Vincenzo Bonifati (V)

Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH